| Literature DB >> 29491254 |
Taishi Higashi1, Daisuke Iohara2, Keiichi Motoyama1, Hidetoshi Arima1,3.
Abstract
Supramolecular chemistry is an extremely useful and important domain for understanding pharmaceutical sciences because various physiological reactions and drug activities are based on supramolecular chemistry. However, it is not a major domain in the pharmaceutical field. In this review, we propose a new concept in pharmaceutical sciences termed "supramolecular pharmaceutical sciences," which combines pharmaceutical sciences and supramolecular chemistry. This concept could be useful for developing new ideas, methods, hypotheses, strategies, materials, and mechanisms in pharmaceutical sciences. Herein, we focus on cyclodextrin (CyD)-based supermolecules, because CyDs have been used not only as pharmaceutical excipients or active pharmaceutical ingredients but also as components of supermolecules.Entities:
Keywords: cyclodextrin (CyD); pharmaceutical sciences; polycatenane; polyrotaxane; supramolecular chemistry; supramolecular pharmaceutical sciences
Mesh:
Substances:
Year: 2018 PMID: 29491254 DOI: 10.1248/cpb.c17-00765
Source DB: PubMed Journal: Chem Pharm Bull (Tokyo) ISSN: 0009-2363 Impact factor: 1.645